Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
• NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.
• NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506766.RAj2A79m1cjpBpR2CUJx5epoHN2Nz_VJvd2nN1MWj_coc130_provenance.
• NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP411899.RAclsw_fgO_by0c2a_k97ft1mN7xYWlCpnnsfKamgGmEo130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411899.RAclsw_fgO_by0c2a_k97ft1mN7xYWlCpnnsfKamgGmEo130_provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP960926.RAXuDk6SluXB7pglBmmplCgqiK159QshLBh0eNK5w-bX0130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960926.RAXuDk6SluXB7pglBmmplCgqiK159QshLBh0eNK5w-bX0130_provenance.
• NP960928.RAoPZmlMe0SLy1GLOTLQRVGpgEjX7rObecNWk-lZ0P5rA130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960928.RAoPZmlMe0SLy1GLOTLQRVGpgEjX7rObecNWk-lZ0P5rA130_provenance.
• NP960933.RAr2mhwJ5E-Rq0KfBibDNT272KFzQwq7pi-GlN2fPRFpk130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960933.RAr2mhwJ5E-Rq0KfBibDNT272KFzQwq7pi-GlN2fPRFpk130_provenance.
• NP960934.RAiiA4axQ2iY9lVJ4C_noRl04PhtBxehEFJ-WLN9SLHfQ130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960934.RAiiA4axQ2iY9lVJ4C_noRl04PhtBxehEFJ-WLN9SLHfQ130_provenance.
• NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.
• NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
• NP960935.RAM50P5TDudHijjkE1Uq8tMaCJcznSD5T442cNz0Ar6lE130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960935.RAM50P5TDudHijjkE1Uq8tMaCJcznSD5T442cNz0Ar6lE130_provenance.
• NP960936.RAPRC8cqR4Hdsvb89uXxK-i9nRZudtbHejzczqA1X6r3o130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960936.RAPRC8cqR4Hdsvb89uXxK-i9nRZudtbHejzczqA1X6r3o130_provenance.
• NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960925.RA0scrIf9FWAnPA8FAgFuZ1XFUQk1m5aMpbiZVtzykTLQ130_provenance.
• NP960929.RA2bI30xWsYoLasquZpXVmOQPauIBJz8XD0zf-0Mvqp9U130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960929.RA2bI30xWsYoLasquZpXVmOQPauIBJz8XD0zf-0Mvqp9U130_provenance.
• NP960932.RA9VMZdBHYclj1qjXZo-IScs2YTqxNHY527SUS2Dhev90130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960932.RA9VMZdBHYclj1qjXZo-IScs2YTqxNHY527SUS2Dhev90130_provenance.